Title:
トレプロスチニルのプロドラッグ
Document Type and Number:
Japanese Patent JP7023891
Kind Code:
B2
Abstract:
Prodrugs of treprostinil are provided which can be used in the treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
Inventors:
Pfister Jurgue
Benkatraman Minakushi
Chang Xiao Min
Becker Cyrus
Risko Rio Gwenaera
Benkatraman Minakushi
Chang Xiao Min
Becker Cyrus
Risko Rio Gwenaera
Application Number:
JP2019109190A
Publication Date:
February 22, 2022
Filing Date:
June 12, 2019
Export Citation:
Assignee:
Corsair Pharma Incorporated
International Classes:
C07C235/20; A61K31/165; A61K31/216; A61K31/341; A61K31/365; A61P9/12; A61P11/00; A61P43/00; C07C69/708; C07D263/26; C07D295/088; C07D307/20; C07D321/00
Domestic Patent References:
| JP6542128B2 | ||||
| JP56138130A | ||||
| JP2007501281A | ||||
| JP2003535132A |
Foreign References:
| WO2012041334A1 |
Attorney, Agent or Firm:
Shimizu Hatsushi
Masao Haruna
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Kazuya Kawamoto
Masao Haruna
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Kazuya Kawamoto
Previous Patent: Method for manufacturing high-conductivity base metal electrodes and alloy low ohm chip resistors
Next Patent: Rotating machine
Next Patent: Rotating machine